Schedule 13G ownership disclosure
CONSTELLATION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 210373106
Event date: 2023-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-23-000674
- Form type
- SC 13G
- Filer
- Lind Global Fund II LP
- CIK
- CIK 1871665
- Filed
- Feb 21, 2023
- Reporting period
- Feb 16, 2023
- Description
- Schedule 13G beneficial ownership